This presentation highlights the growing role of genetic and molecular diagnostics in detecting blood cancers at an early stage. It explains how modern technologies identify cancer-related mutations, abnormal blood cells, and disease progression risks with greater accuracy. The PPT also discusses the benefits of early diagnosis, targeted therapies, and continuous monitoring for better patient outcomes. Advanced cancer marker screening in Dubai helps support timely intervention, personalized treatment strategies, and improved survival rates in blood cancer care. Visit website for more details: https://www.fml-dubai.com/genetic-screening/